soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 in High-Risk Type 2 Diabetes: Benefit Confirmed in the The impact of oral semaglutide

Fella Health reviewed: provider credentialing, pharmacy sourcing, clinical oversight, and program transparency

Clinician-guided GLP-1 medication therapy in El Dorado Hills for men seeking weight and metabolic support

Discover the evidence, risk factors, warning symptoms, and what to do if you suspect pancreatic inflammation whilst taking this type 2 diabetes medication.

New research shows tanning beds give young skin decades worth of DNA damage, sharply raising melanoma risk across the body.

A study of 42,000 adults found increased rates of hypotension events after starting GLP-1s

| Digital health company Hims & Hers launched its much-anticipated weight loss program this week that includes digital tracking tools, educational content and access to medications.